Molica S - Search Results

1

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.

Laurenti L, Innocenti I, Autore F, Ciolli S, Mauro FR, Mannina D, Del Poeta G, D'Arena G, Massaia M, Coscia M, Molica S, Pozzato G, Efremov DG, Vannata B, Marasca R, Galieni P, Cuneo A, Orlando S, Piciocchi A, Boncompagni R, Vincelli D, Liberati AM, Russo F, Foá R. Laurenti L, et al. Among authors: molica s. Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8. Haematologica. 2017. PMID: 28596282 Free PMC article. No abstract available.

2

Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.

Molica S, Alberti A. Molica S, et al. Haematologica. 1990 Jan-Feb;75(1):75-8. Haematologica. 1990. PMID: 2338291

3

Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.

Molica S, De Rossi G, Luciani M, Levato D. Molica S, et al. Haematologica. 1995 Mar-Apr;80(2):176-93. Haematologica. 1995. PMID: 7628755 Review.

4

CD11c expression in B-cell chronic lymphocytic leukemia. A comparison of results obtained with different monoclonal antibodies.

Molica S, Dattilo A, Mannella A, Levato D. Molica S, et al. Haematologica. 1994 Sep-Oct;79(5):452-5. Haematologica. 1994. PMID: 7843632

5

Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up.

Molica S, Levato D, Levato L. Molica S, et al. Haematologica. 1993 Nov-Dec;78(6):374-7. Haematologica. 1993. PMID: 8175032

6

Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.

Molica S, Musto P, Chiurazzi F, Specchia G, Brugiatelli M, Cicoira L, Levato D, Nobile F, Carotenuto M, Liso V, Rotoli B. Molica S, et al. Haematologica. 1996 Mar-Apr;81(2):121-6. Haematologica. 1996. PMID: 8641639 Clinical Trial.

7

Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.

Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P. Molica S, et al. Haematologica. 1996 Sep-Oct;81(5):428-33. Haematologica. 1996. PMID: 8952156

8

Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.

De Rossi G, Marroni P, Paganuzzi M, Mauro FR, Tenca C, Zarcone D, Velardi A, Molica S, Grossi CE. De Rossi G, et al. Among authors: molica s. Leukemia. 1997 Jan;11(1):134-41. doi: 10.1038/sj.leu.2400525. Leukemia. 1997. PMID: 9001429

9

Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.

Molica S, Levato D, Dell' Olio M, Cascavilla N, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P. Molica S, et al. Haematologica. 1997 Mar-Apr;82(2):148-51. Haematologica. 1997. PMID: 9175316

10

Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.

Molica S, Tucci L, Levato D, Docimo C. Molica S, et al. Haematologica. 1997 May-Jun;82(3):286-90. Haematologica. 1997. PMID: 9234573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters